# DHA Supplements to Improve Insulin Sensitivity in Obese Pregnant Women (The Omega-3 Pregnancy Study)

> **NCT00865683** · PHASE1 · UNKNOWN · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 90 (estimated)

## Conditions studied

- Overweight and Obesity
- Insulin Resistance
- Diabetes, Gestational
- Hypertension in Pregnancy
- Pre-Eclampsia

## Interventions

- **DIETARY_SUPPLEMENT:** DHA Supplements
- **DIETARY_SUPPLEMENT:** Placebo Supplements

## Key facts

- **NCT ID:** NCT00865683
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-04
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2009-07-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00865683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00865683, "DHA Supplements to Improve Insulin Sensitivity in Obese Pregnant Women (The Omega-3 Pregnancy Study)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00865683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*